Heart failure is a common complication of obesity [61, 62], and clinical trials have shown that GLP-1 analogs, particularly tirzepatide, can improve cardiac function and reduce the risk of heart failure in people with obesity [63]
GLP-1 receptor agonists multifaceted therapeutic properties extend their benefits to a wide range of pain disorders, including inflammatory, visceral, and neuropathic pain (41, 42)
These coordinated actions on lipid metabolism contribute to steatosis resolution
Use this product in conjunction with food as part of a healthy, balanced diet, not as a substitute for such
Cyanocobalamin dosing in children